Niraxx Light Therapeutics
PrivateLast Round
Series A
Jul 1, 2024
Total Funding Raised
$68,968
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Niraxx Light Therapeutics operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Crowdfunding round in April 2019.
Niraxx Light Therapeutics is a neurotech company that develops wearable healthcare products and digital platforms utilizing photobiomodulation (PBM) technology to treat mental health conditions and improve brain health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Niraxx Light Therapeutics Comparables
Compare Niraxx Light Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sens.ai Incorporated | 87% | |
| Vielight Inc. | 84% | |
| Neuronic | 83% |
For institutional investors. Book with your work email.
Niraxx Light Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2024 | ||||
| Crowdfunding | Apr 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 226% MoM.
- Feb 2, 2026
Monthly visitors grew 45% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Niraxx Light Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Niraxx Light Therapeutics's valuation, stock price, and market status.
Is Niraxx Light Therapeutics a public or private company?
Niraxx Light Therapeutics is a private company.
What is the current stock price of Niraxx Light Therapeutics?
Niraxx Light Therapeutics is a private company, so its shares have no public market price. Caplight tracks Niraxx Light Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Niraxx Light Therapeutics worth (valuation)?
Valuation information for Niraxx Light Therapeutics is not publicly available.
Can I buy Niraxx Light Therapeutics stock?
Niraxx Light Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Niraxx Light Therapeutics's last funding round?
Niraxx Light Therapeutics's most recent funding round was Series A on July 1, 2024.
Who are the main investors in Niraxx Light Therapeutics?
Investor information for Niraxx Light Therapeutics is not publicly disclosed.
Will Niraxx Light Therapeutics IPO soon?
No public IPO plans have been announced for Niraxx Light Therapeutics.
How can I track Niraxx Light Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Niraxx Light Therapeutics's shares on secondary markets.